[ad_1]
STOCKHOLM: Sweden’s Public Well being Company mentioned on Monday it really useful the usage of Pfizer-BioNTech’s , Comirnaty vaccine in opposition to COVID-19 for kids between 12-15, opting in opposition to rival Moderna’s Spikevax.
The European Medicines Company authorized the usage of Comirnaty in Might, whereas Spikevax was given the nod for kids over 12 in July.
“All in all, we see motive to decide on the vaccine that we all know essentially the most about and that’s most well-proven with regards to vaccinating youngsters between 12 and 15 years of age,” Anders Tegnell, head of division and state epidemiologist on the Well being Company mentioned.
The company mentioned there was extra information about Comirnaty’s use on youngsters.
“That is why Spikevax shouldn’t be really useful for the youngest age group in Sweden,” the Company mentioned in a press release. In September, the Company mentioned that youngsters aged 12 and over could be supplied a COVID vaccination beginning October 11.
[ad_2]
Source